GB202017434D0 - Antibody assay - Google Patents

Antibody assay

Info

Publication number
GB202017434D0
GB202017434D0 GBGB2017434.8A GB202017434A GB202017434D0 GB 202017434 D0 GB202017434 D0 GB 202017434D0 GB 202017434 A GB202017434 A GB 202017434A GB 202017434 D0 GB202017434 D0 GB 202017434D0
Authority
GB
United Kingdom
Prior art keywords
antibody assay
antibody
assay
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB2017434.8A
Other versions
GB2600701A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oncimmune Ltd
Original Assignee
Oncimmune Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncimmune Ltd filed Critical Oncimmune Ltd
Priority to GB2017434.8A priority Critical patent/GB2600701A/en
Publication of GB202017434D0 publication Critical patent/GB202017434D0/en
Priority to US18/005,568 priority patent/US20230266331A1/en
Priority to PCT/EP2021/069668 priority patent/WO2022013321A2/en
Priority to KR1020237004771A priority patent/KR20230068378A/en
Priority to EP21743191.5A priority patent/EP4182693A2/en
Priority to JP2023502699A priority patent/JP2023533815A/en
Priority to CN202180062774.5A priority patent/CN116324412A/en
Publication of GB2600701A publication Critical patent/GB2600701A/en
Withdrawn legal-status Critical Current

Links

GB2017434.8A 2020-07-14 2020-11-04 Antibody assay Withdrawn GB2600701A (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
GB2017434.8A GB2600701A (en) 2020-11-04 2020-11-04 Antibody assay
US18/005,568 US20230266331A1 (en) 2020-07-14 2021-07-14 Use of antigen combination for detecting autoantibodies in lung cancer
PCT/EP2021/069668 WO2022013321A2 (en) 2020-07-14 2021-07-14 Antibody assay
KR1020237004771A KR20230068378A (en) 2020-07-14 2021-07-14 Use of Antigen Combinations to Detect Autoantibodies in Lung Cancer
EP21743191.5A EP4182693A2 (en) 2020-07-14 2021-07-14 Use of antigen combination for detecting autoantibodies in lung cancer
JP2023502699A JP2023533815A (en) 2020-07-14 2021-07-14 Use of antigen combinations to detect autoantibodies in lung cancer
CN202180062774.5A CN116324412A (en) 2020-07-14 2021-07-14 Use of antigen combinations for detection of autoantibodies in lung cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2017434.8A GB2600701A (en) 2020-11-04 2020-11-04 Antibody assay

Publications (2)

Publication Number Publication Date
GB202017434D0 true GB202017434D0 (en) 2020-12-16
GB2600701A GB2600701A (en) 2022-05-11

Family

ID=73776512

Family Applications (1)

Application Number Title Priority Date Filing Date
GB2017434.8A Withdrawn GB2600701A (en) 2020-07-14 2020-11-04 Antibody assay

Country Status (1)

Country Link
GB (1) GB2600701A (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999058978A2 (en) 1998-05-11 1999-11-18 The University Of Nottingham Tumour markers
WO2004044590A1 (en) 2002-11-14 2004-05-27 The University Of Nottingham Tumour marker proteins and uses thereof
WO2006126008A2 (en) 2005-05-27 2006-11-30 Oncimmune Limited Improved immunoassay methods
WO2015193678A1 (en) 2014-06-20 2015-12-23 Oncimmune Limited Improved immunoassay methods

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103869086B (en) * 2014-04-14 2016-02-17 杭州凯保罗生物科技有限公司 A kind of autoantibodies detection kit

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999058978A2 (en) 1998-05-11 1999-11-18 The University Of Nottingham Tumour markers
WO2004044590A1 (en) 2002-11-14 2004-05-27 The University Of Nottingham Tumour marker proteins and uses thereof
WO2006126008A2 (en) 2005-05-27 2006-11-30 Oncimmune Limited Improved immunoassay methods
WO2015193678A1 (en) 2014-06-20 2015-12-23 Oncimmune Limited Improved immunoassay methods

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
CHAPMAN ET AL., TUMOR BIOL, vol. 33, 2012, pages 1319 - 1326
E. DIAMANDIST. CHRISTOPOULUS: "Immunoassay", 1996, ACADEMIC PRESS, INC.
HANGZHOU CANCER PROBE BIOTECHNOLOGY COMPANY, SEVEN KINDS OF AUTOANTIBODIES TEST KIT
REN ET AL., ONCOIMMUNOLOGY, vol. 7, no. 2, 2017

Also Published As

Publication number Publication date
GB2600701A (en) 2022-05-11

Similar Documents

Publication Publication Date Title
EP4025908A4 (en) Anti-drug antibody assay
GB202011617D0 (en) Assay
GB202016699D0 (en) Antibody assay
GB202015115D0 (en) ZIP12 Antibody
GB202017434D0 (en) Antibody assay
GB202014851D0 (en) SARS-COV-2 antibodies
GB202213127D0 (en) Antibody assay
GB202101700D0 (en) Antibody detection assay
GB202014047D0 (en) Sars-cov-2 antibody detection assay
GB202011047D0 (en) Sars-cov-2 antibody detection assay
IL307174A (en) Assay
GB202119033D0 (en) Assay
GB202117513D0 (en) Assay
GB202115072D0 (en) Assay
GB202115077D0 (en) Assay
GB202112296D0 (en) Assay
GB202106027D0 (en) Antibody
GB202105933D0 (en) Anti-IL1rap antibody
GB202109886D0 (en) Assay
GB202108853D0 (en) Assay
GB202105117D0 (en) Assay
GB202014969D0 (en) ZIP12 antibody
GB202100902D0 (en) Calprotectin assay
GB202015211D0 (en) Assay
GB202015122D0 (en) Assay

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)